Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear HPV DNA VIA) in North America

January 2017 | 49 pages | ID: CBEC3A6886AEN
Renub Research

Abstracts

Cervical cancer is one of the most common causes of cancer death for North American women. It is estimated that over 4,000 women in the United States and 400 women in Canada die from cervical cancer in 2016. However, it is also one of the most preventable types of cancer. Pap smear and HPV DNA test are two most popular testing methods to diagnose cervical cancer cases in North America. United States is the leader in North America cervical cancer test market. It holds over 90 percent testing population share alone, and is likely to maintain its position in forecasting period as well due to women getting regular Pap tests.

Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear HPV DNA VIA) in North America report published by Renub Research provides a comprehensive analysis and forecast till 2020. This report provides a complete analysis of 2 Countries Cervical Cancer Test Market & Number of Cervical Cancer Population. All the 2 countries in the report have been studied from 3 viewpoints.

North America Cervical Cancer Test Market, Volume & Mortality

1. Cervical cancer Test Population (2008-2020)

• Pap smear test population (2008-2020)
• HPV DNA test population (2008-2020)

2. Cervical Cancer Mortality Population (2001-2011)
3. Cervical Cancer Test Market (2008-2020)

• Pap smear test market (2008-2020)
• HPV DNA test market (2008-2020)

Countries studied in the report are as follows

• United States
• Canada

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 1000 paid databases.

Contents

1. EXECUTIVE SUMMARY

2. NORTH AMERICA CERVICAL CANCER TEST (SCREENING) POPULATION & FORECAST

3. NORTH AMERICA CERVICAL CANCER TEST (SCREENING) MARKET & FORECAST

3.1 North America Cervical Cancer Pap Smear Test (Screening) Market & Forecast
3.2 North America Cervical Cancer HPV DNA Test (Screening) Market & Forecast

4. NORTH AMERICA CERVICAL CANCER TEST (SCREENING) POPULATION SHARE, MARKET SHARE & FORECAST

4.1 North America Cervical Cancer Test (Screening) Population Share & Forecast
4.2 North America Cervical Cancer Test (Screening) Market Share & Forecast
4.3 North America Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast
4.4 North America Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast

5. UNITED STATES – CERVICAL CANCER TEST ANALYSIS

5.1 United States Cervical Cancer Test (Screening) Population
  5.1.1 United States Cervical Cancer Pap Smear Test Population & Forecast
  5.1.2 United States Cervical Cancer HPV DNA Test Population & Forecast
5.2 United States Cervical Cancer Mortality
5.3 United States Cervical Cancer Test (Screening) Market
  5.3.1 United States Cervical Cancer Test Market & Forecast
  5.3.2 United States Pap smear Test Market & Forecast
  5.3.3 United States HPV DNA Test Market & Forecast

6. CANADA – CERVICAL CANCER TEST ANALYSIS

6.1 Canada Cervical Cancer Test (Screening) Population
  6.1.1 Canada Cervical Cancer Pap Smear Test Population & Forecast
  6.1.2 Canada Cervical Cancer HPV DNA Test Population & Forecast
6.2 Canada Cervical Cancer Mortality
6.3 Canada Cervical Cancer Test (Screening) Market
  6.3.1 Canada Cervical Cancer Test Market & Forecast
  6.3.2 Canada Pap Smear Test Market & Forecast
  6.3.3 Canada HPV DNA Test Market & Forecast

7. CERVICAL CANCER TEST MARKET GROWTH DRIVERS

7.1 Worldwide Rising Incidence of Teenage Sexual Cases
7.2 Worldwide High Prevalence of HPV Infected Patients

8. CHALLENGES IN CERVICAL CANCER TEST MARKET

8.1 Increase HPV Vaccination

List Of Figures

LIST OF FIGURES

Figure 2 1: North America – Cervical Cancer Test Population (Million), 2008 – 2015
Figure 2 2: North America – Forecast for Cervical Cancer Test Population (Million), 2016 – 2020
Figure 3 1: North America – Cervical Cancer Test Market (Million US$), 2008 – 2015
Figure 3 2: North America – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
Figure 3 3: North America – Cervical Cancer Pap Smear Test Market (Million US$), 2008 – 2015
Figure 3 4: North America – Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2016 – 2020
Figure 3 5: North America – Cervical Cancer HPV DNA Test Market (Million US$), 2008 – 2015
Figure 3 6: North America – Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2016 – 2020
Figure 4 1: North America – Cervical Cancer Test Population Share (Percent), 2008 – 2015
Figure 4 2: North America – Forecast for Cervical Cancer Test Population Share (Percent), 2016 – 2020
Figure 4 3: North America – Cervical Cancer Test Market Share (Percent), 2008 – 2015
Figure 4 4: North America – Forecast for Cervical Cancer Test Market Share (Percent), 2016 – 2020
Figure 4 5: North America – Cervical Cancer Pap Smear Test Market Share (Percent), 2008 – 2015
Figure 4 6: North America – Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2016 – 2020
Figure 4 7: North America – Cervical Cancer HPV DNA Test Market Share (Percent), 2008 – 2015
Figure 4 8: North America – Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2016 – 2020
Figure 5 1: United States – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
Figure 5 2: United States – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
Figure 5 3: United States – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
Figure 5 4: United States – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
Figure 5 5: United States – Cervical Cancer Mortality (Number), 2001 – 2011
Figure 5 6: United States – Cervical Cancer Test Market (Million US$), 2008 – 2015
Figure 5 7: United States – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
Figure 5 8: United States – Pap smear Test Market (Million US$), 2008 – 2015
Figure 5 9: United States – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
Figure 5 10: United States – HPV DNA Test Market (Million US$), 2008 – 2015
Figure 5 11: United States – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
Figure 6 1: Canada – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
Figure 6 2: Canada – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
Figure 6 3: Canada – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
Figure 6 4: Canada – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
Figure 6 5: Canada – Cervical Cancer Mortality (Number), 2001 – 2011
Figure 6 6: Canada – Cervical Cancer Test Market (Million US$), 2008 – 2015
Figure 6 7: Canada – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
Figure 6 8: Canada – Pap Smear Test Market (Million US$), 2008 – 2015
Figure 6 9: Canada – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
Figure 6 10: Canada – HPV DNA Test Market (Million US$), 2008 – 2015
Figure 6 11: Canada – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

List Of Tables

LIST OF TABLES

Table 7 1: Worldwide – Prevalence (Percent) of Young Women (15–44 Years) who Have Sex before the Age of 15 Years, 1994 – 2006
Table 7 2: Worldwide – Prevalence of HPV 16/18 in Women with Normal Cervical Cytology (Percent), 2014 - 2015